Instil Bio, Inc.
TIL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$74,135 | -$156,087 | -$223,177 | -$156,794 |
| Dep. & Amort. | $3,610 | $4,756 | $5,987 | $2,752 |
| Deferred Tax | $0 | $0 | $0 | $710 |
| Stock-Based Comp. | $17,257 | $18,166 | $30,441 | $26,197 |
| Change in WC | -$12,605 | -$9,016 | -$9,566 | $4,361 |
| Other Non-Cash | $10,177 | $60,152 | $16,151 | $636 |
| Operating Cash Flow | -$55,696 | -$82,029 | -$180,164 | -$122,138 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$10,000 | -$20,663 | -$84,589 | -$57,831 |
| Net Acquisitions | $0 | $0 | $1,174 | $0 |
| Inv. Purchases | -$135,597 | -$301,466 | -$666,220 | -$1,107,565 |
| Inv. Sales/Matur. | $198,705 | $361,700 | $865,350 | $691,000 |
| Other Inv. Act. | $866 | $1,557 | -$1,174 | $0 |
| Investing Cash Flow | $53,974 | $41,128 | $114,541 | -$474,396 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $2,762 | $8,082 | $70,338 | $0 |
| Stock Issued | $0 | $0 | $1,548 | $339,016 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1,007 | $0 | $0 | $54,148 |
| Financing Cash Flow | $1,755 | $8,082 | $71,886 | $393,164 |
| Forex Effect | -$94 | -$201 | -$637 | -$304 |
| Net Chg. in Cash | -$61 | -$33,020 | $5,626 | -$203,674 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $10,696 | $43,716 | $38,090 | $241,764 |
| End Cash | $10,635 | $10,696 | $43,716 | $38,090 |
| Free Cash Flow | -$65,696 | -$102,692 | -$264,753 | -$179,969 |